Assenagon Asset Management S.A. grew its position in Danaher Corporation (NYSE:DHR – Free Report) by 71.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 37,014 shares of the conglomerate’s stock after acquiring an additional 15,443 shares during the period. Assenagon Asset Management S.A.’s holdings in Danaher were worth $7,338,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Werlinich Asset Management LLC grew its position in Danaher by 9.4% in the 3rd quarter. Werlinich Asset Management LLC now owns 1,165 shares of the conglomerate’s stock valued at $231,000 after acquiring an additional 100 shares in the last quarter. Thrive Wealth Management LLC boosted its position in Danaher by 4.0% in the 3rd quarter. Thrive Wealth Management LLC now owns 6,564 shares of the conglomerate’s stock valued at $1,301,000 after buying an additional 251 shares during the period. Moody National Bank Trust Division grew its stake in shares of Danaher by 6.1% in the third quarter. Moody National Bank Trust Division now owns 9,738 shares of the conglomerate’s stock worth $1,931,000 after acquiring an additional 562 shares in the last quarter. Fragasso Financial Advisors Inc raised its stake in shares of Danaher by 673.1% in the third quarter. Fragasso Financial Advisors Inc now owns 8,434 shares of the conglomerate’s stock valued at $1,813,000 after acquiring an additional 7,343 shares in the last quarter. Finally, Heartwood Wealth Advisors LLC acquired a new position in Danaher during the 3rd quarter worth $37,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on DHR shares. The Goldman Sachs Group started coverage on Danaher in a research report on Tuesday, December 9th. They set a “buy” rating and a $265.00 price objective for the company. Jefferies Financial Group upped their target price on shares of Danaher from $245.00 to $255.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. TD Cowen boosted their price target on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Finally, JPMorgan Chase & Co. boosted their price objective on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $248.25.
Danaher Stock Performance
Shares of DHR opened at $224.78 on Monday. The stock has a market capitalization of $158.77 billion, a P/E ratio of 46.35, a P/E/G ratio of 4.36 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company’s fifty day moving average is $220.37 and its two-hundred day moving average is $207.11.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm earned $1.71 earnings per share. The business’s quarterly revenue was up 4.4% compared to the same quarter last year. On average, sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is presently 26.39%.
Insider Activity
In other news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares in the company, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 30,248 shares of company stock worth $6,609,663 in the last 90 days. 11.20% of the stock is currently owned by corporate insiders.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- I Shouldn’t Be Sending You This
- REVEALED: America just unlocked a $500 trillion asset
- Wall Street Stock picker Names #1 Stock of 2026
- They Laughed at $30. They Won’t Laugh at $70.
- How Long Will $1M Last in Retirement?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
